BrightInsight

BrightInsight is a digital health platform that has gained significant traction since its establishment in 2017. The company's slogan, "BrightInsight is the trusted partner and de facto platform driving value in digital health," encapsulates its primary mission. Specializing in Biopharma and Health Care industries, BrightInsight has secured a noteworthy $101.00M Series C investment on 30 March 2021. This substantial investment was provided by an impressive consortium of backers including Gaingels, Insight Partners, Eclipse Ventures, New Leaf Venture Partners, General Catalyst, SandHill Angels, and Red Hook Capital.

The company's description outlines its provision of cutting-edge technology to aid life sciences firms in rapidly developing, launching, and scaling digital solutions. Its cloud-based platform serves as a dependable foundation for various digital applications such as companion apps, algorithms, connected combination products, and healthcare provider interfaces. Through strategic partnerships, BrightInsight enables its customers to differentiate their therapies and leverage real-world data to drive measurable value. The company has earned recognition as a proven leader in this arena, evidenced by a track record of successful product launches that yield business and clinical ROI for top life sciences companies' flagship brands in their largest markets.

Based in the United States, BrightInsight stands out as a compelling investment prospect within the digital health sector. The recent Series C funding serves as a testament to both its potential and the confidence of prominent investors in its future prospects.